Cyclerion Therapeutics In... (CYCN)
2.40
-0.27 (-10.11%)
At close: Mar 03, 2025, 3:59 PM
2.05
-14.58%
After-hours: Mar 03, 2025, 04:35 PM EST
No 1D chart data available
| Bid | 2.05 |
| Market Cap | 6.5M |
| Revenue (ttm) | 208.14K |
| Net Income (ttm) | -5.67M |
| EPS (ttm) | -2.08 |
| PE Ratio (ttm) | -1.15 |
| Forward PE | -1.87 |
| Analyst | n/a |
| Ask | 2.05 |
| Volume | 61,656 |
| Avg. Volume (20D) | 4,623,881 |
| Open | 2.66 |
| Previous Close | 2.67 |
| Day's Range | 2.38 - 2.66 |
| 52-Week Range | 1.27 - 9.47 |
| Beta | 2.09 |
About CYCN
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's dis...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 18, 2019
Employees 1
Stock Exchange NASDAQ
Ticker Symbol CYCN
Website https://www.cyclerion.com
